Comprehensive Financial Planning, Inc./PA
Position in DNLI — Denali Therapeutics Inc.
CIK 2044855
EAST PETERSBURG, PA
Position in DNLI
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$5,144
+$1,304 QoQ
Shares Held
200
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#241
of 286 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in DNLI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Comprehensive Financial Planning, Inc./PA holds $26,381 across 4 Biotechnology names. DNLI ranks #2 (19.5% of the industry book) .
All Filings in DNLI
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,144 | 200 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $3,840 | 200 | Shares | Sole | 2026-04-07 | |
| 2025-12-31 | $3,302 | 200 | Shares | Sole | 2026-02-11 | |
| No filing history on record for this holder in this stock. | ||||||